Who owns Relmada Therapeutics Inc?
- Ticker: RLMD
- CUSIP Number: 75955j402
Tip: Access positions for across all investors
Analyze quarterly positions in Relmada Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Relmada Therapeutics stock
Who bought or sold Relmada Therapeutics Inc this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Franklin Resources | 1.3M | $677k | 0% | Dec 2024 |
|
| Vanguard Group | 1.3M | $654k | 0% | Dec 2024 |
|
| Acadian Asset Management | 1.2M | $636k | 3% | Dec 2024 |
|
| Deep Track Capital | 675k | $2.2M | -45% | Sep 2024 |
|
| BlackRock | 593k | $309k | 4% | Dec 2024 |
|
| Palo Alto Investors | 495k | $258k | -32% | Dec 2024 |
|
| Vestal Point Capital | 490k | $1.6M | -59% | Sep 2024 |
|
| Geode Capital Management | 303k | $158k | -1% | Dec 2024 |
|
| Deutsche Bank Aktiengesellschaft | 225k | $117k | 0% | Dec 2024 |
|
| UBS Group | 215k | $112k | 70% | Dec 2024 |
|
| AdvisorShares Investments | 210k | $109k | 207% | Dec 2024 |
|
| Susquehanna International | 210k | $109k | 16% | Dec 2024 |
|
| Bank of America Corporation | 207k | $108k | 0% | Dec 2024 |
|
| Tang Capital Management | 201k | $104k | 295% | Dec 2024 |
|
| Two Sigma Advisers | 199k | $103k | -18% | Dec 2024 |
|
| Citadel Advisors | 176k | $92k | 3% | Dec 2024 |
|
| Shay Capital | 176k | $569k | 100% | Sep 2024 |
|
| Renaissance Technologies | 165k | $86k | 535% | Dec 2024 |
|
| Parsons Capital Management | 163k | $85k | -84% | Dec 2024 |
|
| Rbf Capital | 163k | $85k | -1% | Dec 2024 |
|
| Barclays | 146k | $76k | 0% | Dec 2024 |
|
| Two Sigma Investments | 128k | $66k | -33% | Dec 2024 |
|
| GSA Capital Partners | 125k | $65k | 15% | Dec 2024 |
|
| State Street Corporation | 107k | $56k | 8% | Dec 2024 |
|
| Group One Trading | 102k | $53k | 3% | Dec 2024 |
|
| Rosalind Advisors | 100k | $52k | 100% | Dec 2024 |
|
| We Are One Seven | 100k | $52k | 0% | Dec 2024 |
|
| Northern Trust | 84k | $44k | 13% | Dec 2024 |
|
| Bridgeway Capital Management | 73k | $38k | -60% | Dec 2024 |
|
| Citigroup | 63k | $33k | 0% | Dec 2024 |
|
| apricus wealth | 49k | $26k | -38% | Dec 2024 |
|
| Jacobs Levy Equity Management | 46k | $24k | -71% | Dec 2024 |
|
| Ikarian Capital | 40k | $21k | 0% | Dec 2024 |
|
| Jpmorgan Chase & Co | 38k | $20k | -88% | Dec 2024 |
|
| Sei Investments | 36k | $19k | 0% | Dec 2024 |
|
| AlTi Global | 32k | $104k | 0% | Sep 2024 |
|
| FMR | 30k | $16k | -74% | Dec 2024 |
|
| Pensionmark Financial Group | 30k | $15k | -9% | Dec 2024 |
|
| Robertson Stephens Wealth Management | 25k | $13k | 100% | Dec 2024 |
|
| Wolverine Trading | 24k | $11k | 15% | Dec 2024 |
|
| Tortoise Investment Management | 22k | $11k | 0% | Dec 2024 |
|
| Rothschild Investment | 20k | $65k | 100% | Sep 2024 |
|
| Morgan Stanley | 17k | $8.9k | -55% | Dec 2024 |
|
| Dimensional Fund Advisors | 14k | $7.5k | -80% | Dec 2024 |
|
| Sargent Investment Group | 12k | $4.7k | -46% | Dec 2024 |
|
| Beaumont Capital Management | 11k | $5.7k | 100% | Dec 2024 |
|
| Bedel Financial Consulting | 10k | $3.8k | 0% | Dec 2024 |
|
| Hexagon Capital Partners | 4.0k | $2.1k | 0% | Dec 2024 |
|
| American Capital Advisory | 2.0k | $1.0k | 0% | Dec 2024 |
|
| Tower Research Capital | 760.00 | $395.732000 | 100% | Dec 2024 |
|
| Wells Fargo & Company | 200.00 | $104.000000 | -43% | Dec 2024 |
|
| SBI Securities | 102.00 | $52.999200 | 100% | Dec 2024 |
|
| Bnp Paribas Arbitrage, Snc | 72.00 | $37.000800 | 100% | Dec 2024 |
|
| Advisor Group Holdings | 27.00 | $13.999500 | 0% | Dec 2024 |
|
Who sold out of Relmada Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Millennium Management | Sep 2024 | 637k | $2.1M |
| Opaleye Management | Sep 2024 | 480k | $1.6M |
| Silverarc Capital Management | Jun 2024 | 99k | $298k |
| Federated Investors | Sep 2024 | 87k | $283k |
| ExodusPoint Capital Management | Sep 2024 | 68k | $220k |
| ADAR1 Capital Management | Jun 2024 | 51k | $152k |
| Marshall Wace | Sep 2024 | 51k | $164k |
| American Century Companies | Sep 2024 | 32k | $102k |
| Horizon Kinetics Asset Management | Sep 2024 | 30k | $97k |
| Pegasus Asset Management | Sep 2024 | 27k | $87k |
| LPL Financial | Sep 2024 | 14k | $44k |
| Belvedere Trading | Sep 2024 | 13k | $43k |
| Simplex Trading | Sep 2024 | 13k | $40k |
| Charles Schwab Investment Management | Sep 2024 | 13k | $41k |
| Mariner Wealth Advisors | Sep 2024 | 12k | $40k |
| Beacon Pointe Advisors | Sep 2024 | 10k | $33k |
| HighTower Advisors | Sep 2024 | 10k | $32k |
| Cantor Fitzgerald, L. P. | Jun 2024 | 10k | $30k |
| Brown Brothers Harriman & Co. | Sep 2024 | 3.0k | $9.7k |
| Lindbrook Capital | Sep 2024 | 2.5k | $8.1k |
| Royal Bank of Canada | Sep 2024 | 1.5k | $5.0k |
| Fortitude Family Office | Sep 2024 | 252.00 | $816.001200 |
| Golden State Equity Partners | Sep 2024 | 200.00 | $648.000000 |
| Massmutual Trust | Sep 2024 | 113.00 | $365.995700 |
| Larson Financial Group | Sep 2024 | 100.00 | $324.000000 |